Company description

IQVIA Holdings Inc. (ticker IQV) is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. The company was formed in 2016 through the merger of Quintiles Transnational Holdings Inc. and IMS Health Holdings Inc. With over 70,000 employees in more than 100 countries, IQVIA works closely with pharmaceutical, biotechnology, and medical device companies to help them develop and commercialize innovative medicines and treatments. The company offers a wide range of services, including clinical research, data science, consulting, and technology solutions, all aimed at improving patient outcomes and driving healthcare forward. IQVIA has a strong track record of success, with a portfolio of over 100,000 studies completed and over $18 billion in revenue in 2019. It has also been recognized as a top employer, with a strong focus on diversity, inclusion, and employee development. IQVIA continues to innovate and invest in cutting-edge technologies such as artificial intelligence and machine learning to stay at the forefront of the rapidly evolving healthcare industry. With its global reach, deep expertise, and commitment to excellence, IQVIA is well-positioned for continued growth and success in the future.